A Pharmacokinetic Evaluation of Levonorgestrel Implant and Non-nucleoside Reverse Transcriptase Inhibitor (NNRTI)-Based Antiretroviral Therapy in HIV-infected Ugandan Women
Phase of Trial: Phase II
Latest Information Update: 06 Apr 2016
At a glance
- Drugs Levonorgestrel (Primary) ; Efavirenz; Nevirapine
- Indications HIV-1 infections; Pregnancy
- Focus Pharmacokinetics
- Acronyms LNG-NNRTI PK
- 31 Mar 2016 Status changed from active, no longer recruiting to completed, according to ClinicalTrials.gov record.
- 08 Dec 2015 Results published in the Clinical Infectious Diseases
- 11 Feb 2014 Status changed to active, no longer recruiting according to ClinicalTrials.gov record .